Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers	Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm	Not yet recruiting	Phase 2	2026-01-08		NCT07126561

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Chicago	326

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials